Evaluation of Oral Contraceptive Suitability
Measure blood pressure before prescribing combined oral contraceptives to every woman—this is the only mandatory clinical investigation required 1.
Essential Pre-Prescription Assessment
Mandatory Clinical Measurement
- Blood pressure measurement is the single essential examination required before COC prescription, regardless of personal or family history 1
- This is classified as the only "Class A" requirement (essential and mandatory in all circumstances) for safe COC use
Critical History Elements
Absolute Contraindications (Category 4 - Unacceptable Health Risk):
Age and Smoking:
- Age ≥35 years AND smoking ≥15 cigarettes daily 2
- Combined contraception is formally contraindicated in smokers over 35, especially when consumption exceeds 15 cigarettes daily 1
Cardiovascular History:
- Personal history of arterial events (coronary heart disease, stroke) 1
- Current or history of ischemic heart disease 2
- Acute VTE or history of VTE with risk factors for recurrence 2
- Known thrombogenic mutations (Factor V Leiden, prothrombin mutation, protein S/C deficiency, antithrombin deficiency) 2
- Migraine with aura 2
Blood Pressure:
- SBP ≥160 mmHg or DBP ≥100 mmHg 2
- First-line COC is contraindicated in women with hypertension, except those with only a history of pregnancy-related hypertension 1
Other Absolute Contraindications:
- Current breast cancer 2
- Severe or decompensated cirrhosis 2
- Hepatocellular adenoma or malignant liver tumor 2
- Peripartum cardiomyopathy with impaired function ≤6 months 2
Relative Contraindications (Category 3 - Risks Usually Outweigh Benefits):
- Age ≥35 years AND smoking <15 cigarettes daily 2
- SBP 140-159 mmHg or DBP 90-99 mmHg 2
- Exception: Women under 35 on effective antihypertensive treatment without complications or other cardiovascular risk factors may use COC (relative contraindication) 1
- VTE history with no risk factors for recurrence 2
- Past breast cancer with no evidence of disease for 5 years 2
Diabetes-Specific Considerations:
- Type 1 diabetes: COC acceptable if no risk factors (dyslipidemia, hypertension, smoking, diabetes >20 years) and no complications (nephropathy, advanced retinopathy, cardiovascular disease, neuropathy) 1
- Type 2 diabetes: Progestin-only contraception, levonorgestrel implant, or IUD preferred as first-line 1
- Diabetes with nephropathy, retinopathy, neuropathy, other vascular disease, or duration ≥20 years is an absolute contraindication 2
Acceptable Use Scenarios
Before age 35:
- Combined hormonal contraception may be used regardless of number of cigarettes smoked, if no other cardiovascular risk factors present 1
Postpartum timing:
- Contraindicated during first 3 weeks postpartum (Category 4) due to VTE risk 2, 3
- Generally should not use during fourth week postpartum (Category 3) 3
Clinical Decision Algorithm
- Measure blood pressure (mandatory)
- Screen for absolute contraindications (Category 4):
- If present → Do not prescribe COC; offer progestin-only methods or non-hormonal alternatives
- Screen for relative contraindications (Category 3):
- If present → Carefully weigh risks vs. benefits; strongly consider progestin-only alternatives
- Assess age and smoking status together (not separately)
- For diabetes: Assess type, duration, complications, and other risk factors
Common Pitfalls to Avoid
- Do not rely on unaided patient self-assessment: Sensitivity is only 56% for detecting true contraindications 4
- Unrecognized hypertension is the most common missed contraindication: 6.6% of women incorrectly thought they were eligible when contraindicated, largely due to undiagnosed hypertension 4
- Migraine misclassification: 7% incorrectly thought they were contraindicated, primarily from misclassifying migraine headaches 4
- Do not prescribe based on age alone: Age must be considered in context with smoking status and other risk factors 1
Alternative Options When COC Contraindicated
Progestin-only methods are preferred alternatives for:
- Hypertensive women 1
- Smokers of any age 1
- Women with diabetes complications 1
- Women with cardiovascular risk factors (after multidisciplinary discussion) 1
The actual prevalence of true medical contraindications to COC in reproductive-aged women seeking contraception is low (2.38%) 5, making COC a safe option for most women when properly screened.